S. Elizabeth Franks - Search Results

Year	Number of Results
2016	3
2018	1
2019	2
2020	2
2021	2
2022	2
2023	1
2024	0

1

Targeting B cells in treatment of autoimmunity.

Franks SE, Getahun A, Hogarth PM, Cambier JC. Franks SE, et al. Curr Opin Immunol. 2016 Dec;43:39-45. doi: 10.1016/j.coi.2016.09.003. Epub 2016 Oct 5. Curr Opin Immunol. 2016. PMID: 27718447 Free PMC article. Review.

2

Natural Born Killers: NK Cells in Cancer Therapy.

Franks SE, Wolfson B, Hodge JW. Franks SE, et al. Cancers (Basel). 2020 Jul 31;12(8):2131. doi: 10.3390/cancers12082131. Cancers (Basel). 2020. PMID: 32751977 Free PMC article. Review.

3

Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12.

Franks SE, Santiago-Sanchez GS, Fabian KP, Solocinski K, Chariou PL, Hamilton DH, Kowalczyk JT, Padget MR, Gameiro SR, Schlom J, Hodge JW. Franks SE, et al. Cancer Immunol Immunother. 2023 Aug;72(8):2783-2797. doi: 10.1007/s00262-023-03459-7. Epub 2023 May 11. Cancer Immunol Immunother. 2023. PMID: 37166485 Free PMC article.

4

Stay on Target: Reengaging Cancer Vaccines in Combination Immunotherapy.

Wolfson B, Franks SE, Hodge JW. Wolfson B, et al. Among authors: franks se. Vaccines (Basel). 2021 May 15;9(5):509. doi: 10.3390/vaccines9050509. Vaccines (Basel). 2021. PMID: 34063388 Free PMC article. Review.

5

Putting on the Brakes: Regulatory Kinases and Phosphatases Maintaining B Cell Anergy.

Franks SE, Cambier JC. Franks SE, et al. Front Immunol. 2018 Apr 6;9:665. doi: 10.3389/fimmu.2018.00665. eCollection 2018. Front Immunol. 2018. PMID: 29681901 Free PMC article. Review.

6

Eosinophils Decrease Pulmonary Metastatic Mammary Tumor Growth.

Cederberg RA, Franks SE, Wadsworth BJ, So A, Decotret LR, Hall MG, Shi R, Hughes MR, McNagny KM, Bennewith KL. Cederberg RA, et al. Front Oncol. 2022 Jun 8;12:841921. doi: 10.3389/fonc.2022.841921. eCollection 2022. Front Oncol. 2022. PMID: 35756626 Free PMC article.

7

Immune targeting of three independent suppressive pathways (TIGIT, PD-L1, TGFβ) provides significant antitumor efficacy in immune checkpoint resistant models.

Franks SE, Fabian KP, Santiago-Sánchez G, Wolfson B, Hodge JW. Franks SE, et al. Oncoimmunology. 2022 Oct 1;11(1):2124666. doi: 10.1080/2162402X.2022.2124666. eCollection 2022. Oncoimmunology. 2022. PMID: 36211806 Free PMC article.

8

A Precision B Cell-Targeted Therapeutic Approach to Autoimmunity Caused by Phosphatidylinositol 3-Kinase Pathway Dysregulation.

Franks SE, Getahun A, Cambier JC. Franks SE, et al. J Immunol. 2019 Jun 15;202(12):3381-3393. doi: 10.4049/jimmunol.1801394. Epub 2019 May 10. J Immunol. 2019. PMID: 31076529 Free PMC article.

9

Germinal center hypoxia in tumor-draining lymph nodes negatively regulates tumor-induced humoral immune responses in mouse models of breast cancer.

Firmino NS, Cederberg RA, Lee CM, Shi R, Wadsworth BJ, Franks SE, Thomas KN, Decotret LR, Bennewith KL. Firmino NS, et al. Among authors: franks se. Oncoimmunology. 2021 Aug 4;10(1):1959978. doi: 10.1080/2162402X.2021.1959978. eCollection 2021. Oncoimmunology. 2021. PMID: 34377597 Free PMC article.

10

Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation.

Wadsworth BJ, Cederberg RA, Lee CM, Firmino NS, Franks SE, Pan J, Colpo N, Lin KS, Benard F, Bennewith KL. Wadsworth BJ, et al. Among authors: franks se. Cancer Lett. 2020 Nov 28;493:31-40. doi: 10.1016/j.canlet.2020.07.015. Epub 2020 Aug 4. Cancer Lett. 2020. PMID: 32763272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year